Okmetic Oyj - Decisions of general meeting

DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ

OKMETIC OYJ            STOCK EXCHANGE RELEASE     7 APRIL 2011    AT 2.00 P.M.


DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ

The annual general meeting of Okmetic Oyj was held on 7 April 2011, at 10.00
a.m. in the Akropolis hall of Technopolis, at the address Teknobulevardi
3-5, 01530 Vantaa, Finland. The annual general meeting adopted the financial
statements for the financial year 2010 and discharged the company's management
from liability.

USE OF THE PROFITS SHOWN ON THE BALANCE SHEET AND PAYMENT OF DIVIDEND

The annual general meeting decided, in accordance with the proposal of the board
of directors, to distribute a dividend of 0.30 euro per share. Dividend will be
paid to a shareholder, who, on the record date 12 April 2011, is registered in
the shareholders' register held by Euroclear Finland Ltd. Dividend will be paid
on 19 April 2011.

In addition, the annual general meeting decided, in accordance with the proposal
of the board of directors, to authorise the board of directors to decide upon
its discretion on the payment of an additional dividend, should the company's
financial situation permit this. The additional dividend, including any number
of separate decisions on dividend payment, may amount up to a maximum of 0.40
euro per share and 15,000,000 euro in total. The authorisation is effective
until the beginning of the next annual general meeting. Any dividend paid on the
basis of the board's decision will be paid to such shareholder who, on the
record date determined by the board of directors, is registered in the
shareholders' register held by Euroclear Finland Ltd. The board of directors
will decide the record date of the dividend payout and the dividend payment date
which may, at the earliest, be the fifth banking day after the record date.

ELECTION AND REMUNERATION OF THE MEMBERS OF THE BOARD OF DIRECTORS

It was decided that there would be five members on the company's board of
directors. Mr. Henri Österlund, Mr. Tapani Järvinen, Mr. Hannu Martola, and Mr.
Pekka Salmi were re-elected as members of the board of directors until the end
of the next annual general meeting, and Ms. Mervi Paulasto-Kröckel was elected
as a new member. The board of directors elected Henri Österlund as its chairman
and Tapani Järvinen as its vice chairman in its organisation meeting held
immediately after the annual general meeting.

It was decided, that the following annual remuneration shall be paid to the
members of the board of directors: 40,000 euro to the chairman and 30,000 euro
to the vice chairman of the board of directors and 20,000 euro to the other
members of the board of directors. The annual remuneration will be paid in the
company's shares and in cash for the part of taxes. In addition, it was decided
that the board members will be paid meeting remuneration, amount of which is
750 euro/meeting for the chairman and 500 euro/meeting for other board members.

ELECTION AND REMUNERATION OF THE AUDITOR

Authorised Public Accountants PricewaterhouseCoopers Oy was re-elected as
auditor of the company. PricewaterhouseCoopers Oy has announced that APA Mikko
Nieminen will be acting as principal auditor. It was decided that remuneration
to the auditor shall be paid according to the auditor's reasonable invoice.

AUTHORISING THE BOARD OF DIRECTORS TO DECIDE ON THE REPURCHASE AND/OR ON THE
ACCEPTANCE AS PLEDGE OF THE COMPANY'S OWN SHARES

The general meeting authorised the board of directors to decide on the
repurchase and/or on the acceptance as pledge of the company's own shares as
follows:

The aggregate number of own shares to be repurchased and/or accepted as pledge
shall not exceed 1,728,750 shares, which represents approximately 10 percent of
all the shares in the company. The company and its subsidiaries together cannot
at any time own and/or hold as pledge more than 10 percent of all the company's
registered shares.

Only the unrestricted equity of the company can be used to repurchase the
company's own shares on the basis of the authorisation. Own shares can be
repurchased at a price determined by public trading on the day of the repurchase
or at another market-based price.

The board of directors decides how own shares will be repurchased and/or
accepted as pledge, as well as the other terms and conditions. Shares can be
repurchased using, inter alia, derivatives. Shares can be repurchased
independently of the shareholders' proportional share holdings (directed
repurchase). The authorisation is effective until the next annual general
meeting, however, no longer than until 7 October 2012.

AUTHORISING THE BOARD OF DIRECTORS TO DECIDE ON TRANSFERRING RIGHTS TO THE
COMPANY'S OWN SHARES

The general meeting authorised the board of directors to decide on transferring
rights to the company's own shares as follows:

The aggregate number of rights transferred on the basis of the authorisation
cannot exceed 1,728,750 shares, which represents approximately 10 percent of all
the shares in the company.

The board of directors is authorised to decide on all the terms and conditions
of the issuance of shares. The authorisation is limited to the transfer of own
shares held by the company. The share issue can be carried out as a directed
issue. The board of directors may also decide to cancel the repurchased shares.

The authorisation is effective until the next annual general meeting. The
authorisation cancels the authorisation granted at the extraordinary general
meeting of 6 November 2008 regarding the transfer of the company's own shares.

AUTHORISING THE BOARD OF DIRECTORS TO DECIDE ON THE ISSUANCE OF SHARES AS WELL
AS THE ISSUANCE OF SPECIAL RIGHTS ENTITLING TO SHARES

The general meeting authorised the board of directors to decide on the issuance
of shares and special rights entitling to shares referred to in chapter 10
section 1 of the Companies Act as follows:

The amount of shares to be issued on the basis of the authorisation shall not
exceed 3,457,500 shares, which represents approximately 20 percent of all the
shares in the company.

The board of directors is authorised to decide on all the terms and conditions
of the issuance of shares and of special rights entitling to shares. The
authorisation concerns the issuance of new shares. The issuance of shares and of
special rights entitling to shares may be carried out as a directed issue.

The authorisation is effective until the next annual general meeting, however,
no longer than until 7 October 2012, and does not cancel other authorisations
that were given at the same annual general meeting.

PRESIDENT'S REVIEW AT THE ANNUAL GENERAL MEETING

The review of President Kai Seikku is available on the company's website at
www.okmetic.com/www/page/presentation_materials.


OKMETIC OYJ

Kai Seikku
President

For further information, please contact:

Kai Seikku, President, Okmetic Oyj,
Tel. +358 400 200 288, e-mail: kai.seikku@okmetic.com

Juha Jaatinen, Senior Vice President, Finance, IT, and Communications, Okmetic
Oyj, tel. +358 5028 0286, e-mail: juha.jaatinen@okmetic.com


Distribution:
NASDAQ OMX Helsinki Ltd
Principal media
www.okmetic.fi


OKMETIC IN BRIEF

Take it higher

Okmetic is a technology company which supplies tailor-made silicon wafers for
sensor and semiconductor industries and sells its technological expertise to the
solar cell industry. Okmetic provides its customers with solutions that boost
their competitiveness and profitability.

Okmetic's silicon wafers are part of a further processing chain that produces
end products that improve human interaction and quality of life. The company's
products are based on high-tech expertise that generates added value for
customers, innovative product development and an extremely efficient production
process.

Okmetic has a worldwide clientele and sales network, production plants in
Finland and in the United States as well as license-based production in Japan
and in China.

Ocmetic's shares are listed on the NASDAQ OMX Helsinki Ltd under the trading
symbol OKM1V. Additional information can be found on the company's website:
www.okmetic.com.



[HUG#1504422]

Attachments:

OKME0911.pdf